Fanny Leenhardt

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Squamous Cell Carcinoma

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Transcranial Magnetic Stimulation

Top Venues

International journal of molecular sciences

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte Donzé, Fanny Leenhardt, Marie Vinches, Marie-Claude Eberlé, Cyril Fersing
Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Charlotte Donzé, Fanny Leenhardt, Marie Vinches, Marie-Claude Eberlé, Cyril Fersing
Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Charlotte Donzé, Fanny Leenhardt, Marie Vinches, Marie-Claude Eberlé, Cyril Fersing
Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report. Medicina (Kaunas, Lithuania) 60 (7) (2024)
Quentin Dominique Thomas, Nelly Firmin, Litaty Mbatchi, Alexandre Evrard, Xavier Quantin, Fanny Leenhardt
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key. International journal of molecular sciences 24 (6) (2023)
Quentin Dominique Thomas, Nelly Firmin, Litaty Mbatchi, Alexandre Evrard, Xavier Quantin, Fanny Leenhardt
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key. International journal of molecular sciences 24 (6) (2023)
Quentin Dominique Thomas, Nelly Firmin, Litaty Mbatchi, Alexandre Evrard, Xavier Quantin, Fanny Leenhardt
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key. International journal of molecular sciences 24 (6) (2023)
Clément Carbasse, Fanny Leenhardt, William Jacot, Caroline Perrier, Frederic Pinguet, Marie Viala
Oral targeted therapy dose adaptation in older patients with cancer: A real-life French cohort. British journal of clinical pharmacology 88 (7) (2022)
Fanny Leenhardt, Marie Viala, Diego Tosi, Emmanuelle Samalin-Scalzi, Alexandre Evrard, Litaty C Mbatchi
Therapeutic Bayesian monitoring of sunitinib in two patients with impaired absorption or elimination. Journal of clinical pharmacy and therapeutics 46 (4) (2021)
Alice Matheux, Matthieu Gassiot, Gaelle Fromont, Fanny Leenhardt, Abdelhay Boulahtouf, Eric Fabbrizio, Candice Marchive, Aurélie Garcin, Hanane Agherbi, Eve Combès, Alexandre Evrard, Nadine Houédé, Patrick Balaguer, Céline Gongora, Litaty C Mbatchi, Philippe Pourquier
PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1. Cancers 13 (14) (2021)
Fanny Leenhardt, Marie Alexandre, Severine Guiu, Stephane Pouderoux, Melanie Beaujouin, Gerald Lossaint, Laurent Philibert, Alexandre Evrard, William Jacot
Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug-drug interactions with oral targeted therapy. Cancer chemotherapy and pharmacology 88 (4) (2021)
Félicien Le Louedec, Fanny Leenhardt, Clémence Marin, Étienne Chatelut, Alexandre Evrard, Joseph Ciccolini
Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic Perspective. Vaccines 8 (4) (2020)